3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
17
Myelodysplastic Syndromes
9
Leukemia, Myelomonocytic, Chronic
4
Myeloproliferative Disorders
3
Myelodysplastic-Myeloproliferative Diseases
2
Leukemia, Biphenotypic, Acute
2
Triple Negative Breast Neoplasms
1
Thrombocythemia, Essential
1
Systemic Mastocytosis With an Associated Hematologic Neoplasm
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Mesothelioma, Malignant
1
Mesothelioma
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, B-Cell
1
Hodgkin Disease
1
GATA2 Deficiency
1
Cytopenia
1
Central Nervous System Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Carcinoma, Merkel Cell
1
BRCA1 Mutation
1
Anemia, Refractory, with Excess of Blasts
1
Allogeneic Stem Cell Transplantation
1
Interventions
ponatinib
3
asciminib
3
nilotinib
2
fludarabine phosphate
2
Whole-Body Irradiation
2
Specimen Handling
2
Melphalan
2
Dasatinib
2
Cyclophosphamide
2
Busulfan
2
venetoclax
1
ruxolitinib
1
pembrolizumab
1
pegylated granulocyte colony-stimulating factor
1
letermovir
1
Tyrosine Kinase Inhibitors
1
Tacrolimus
1
Stem Cell Transplantation
1
Sirolimus
1
Rituximab
1
Pharmaceutical Preparations
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Interviews as Topic
1
Imatinib Mesylate
1
Etoposide
1
Cyclosporine
1
Cord Blood Stem Cell Transplantation
1
Clofarabine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myeloid, Chronic-Phase
×
decitabine and cedazuridine drug combination
×
90 days
×
Clear all
No trials found.